The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is a component of the National Institutes of Health (NIH) that supports biomedical and behavioral research to reduce the burden of arthritis and musculoskeletal and skin diseases in the United States. For the benefit of patients, the mission of NIAMS is to conduct and support research on the causes, treatments, and prevention of arthritis and musculoskeletal and skin diseases, and to train future health professionals. NIAMS is one of the five institutes of NIH, the others being the National Cancer Institute, the National Institute of Mental Health, the National Heart, Lung, and Blood Institute, and the National Institute on Aging. It is responsible for the processing of applications for research grants, the development and maintenance of standards and quality control, the coordination of grants awards, and the dissemination of information about its programs.
Physical rehabilitation to recover normal function of bodily structures after amputation is an important subject in medicine. The research in biomechanics might play a role in designing new prostheses and rehabilitation techniques, including active exoskeletons to support, protect, and restore the function of lower-limb amputees.
The NIDDK is a component of the National Institutes of Health that supports basic research on diseases that affect the body and on the normal structure and function of the body. NIDDK work includes the study of cell and molecular biology, genetics, biochemistry, physiology, and epidemiology. NIDDK also funds research on the prevention and treatment of human diseases.
The high cost of neuromuscular disorders and their consequences for the economy and society make it necessary to find simple, non-invasive, and inexpensive methods that are able to detect these disorders at an early stage. The analysis of the waveforms of muscle action potential, EMG, could provide useful diagnostic tools. In a recent study, it has been demonstrated that the detection of the phase 2 of the post-tetanic discharge (PSTD) of single motor units could be a reliable method of detecting neuropathy. This study confirmed the ability of the proposed method to detect even mild peripheral neuropathy with high sensitivity and specificity. In another recent study, a new non-invasive method for detecting peripheral neuropathy has been introduced. This method is based on the evaluation of the amplitude of the evoked compound muscle action potentials (EMAPs) measured in the vastus lateralis and the tibialis anterior muscles of the lower limbs. The method is based on the comparison between the EMAPs recorded in an affected limb and those recorded in a healthy contralateral limb. The results of these studies demonstrate that the proposed method can be a useful clinical tool in the early detection of peripheral neuropathy.
Jolene Fu, a member of the DARPA Robotics Challenge, a technology team at NASA, Army Research Laboratory, and a NASA Johnson Space Center researcher, and her team finished the race on the robotic platform, which is able to go at least 500 meters with a payload of up to 50 kilograms (Figure 3). 827ec27edc